C000000433 Holdings — Invesco V.I. Health Care Fund
All 81 reported holdings of Invesco V.I. Health Care Fund (C000000433) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Co. | 10.84% | $17.41M |
| Invesco Private Prime Fund | 7.90% | $12.69M |
| Johnson & Johnson | 6.27% | $10.08M |
| UnitedHealth Group Inc. | 6.08% | $9.77M |
| Merck & Co., Inc. | 4.20% | $6.74M |
| argenx SE | 3.98% | $6.39M |
| AbbVie Inc. | 3.98% | $6.39M |
| Gilead Sciences, Inc. | 3.45% | $5.54M |
| Invesco Private Government Fund | 3.04% | $4.88M |
| AstraZeneca PLC | 2.93% | $4.71M |
| BrightSpring Health Services, Inc. | 2.72% | $4.38M |
| Welltower Inc. | 2.21% | $3.56M |
| CVS Health Corp. | 2.19% | $3.52M |
| Cardinal Health, Inc. | 2.11% | $3.39M |
| Vertex Pharmaceuticals Inc. | 2.05% | $3.29M |
| Royalty Pharma PLC | 2.00% | $3.21M |
| Guardant Health, Inc. | 1.85% | $2.98M |
| Axsome Therapeutics, Inc. | 1.74% | $2.79M |
| Invesco Treasury Portfolio | 1.62% | $2.61M |
| Edwards Lifesciences Corp. | 1.60% | $2.58M |
| U C B S.a. | 1.41% | $2.27M |
| BridgeBio Pharma, Inc. | 1.30% | $2.10M |
| Ligand Pharmaceuticals Inc. | 1.26% | $2.03M |
| Sandoz Group AG | 1.24% | $1.99M |
| Waters Corp. | 1.20% | $1.93M |
| Ascendis Pharma A/S | 1.17% | $1.89M |
| Natera, Inc. | 1.15% | $1.85M |
| Revolution Medicines, Inc. | 1.07% | $1.71M |
| Protagonist Therapeutics, Inc. | 1.03% | $1.66M |
| United Therapeutics Corp. | 1.01% | $1.62M |
| Intuitive Surgical, Inc. | 0.98% | $1.58M |
| Halozyme Therapeutics, Inc. | 0.98% | $1.58M |
| IQVIA Holdings Inc. | 0.95% | $1.52M |
| Madrigal Pharmaceuticals, Inc. | 0.92% | $1.48M |
| Galderma Group AG | 0.92% | $1.47M |
| Medline Inc. | 0.84% | $1.36M |
| Invesco Government & Agency Portfolio | 0.83% | $1.34M |
| West Pharmaceutical Services, Inc. | 0.81% | $1.31M |
| Mettler-Toledo International Inc. | 0.81% | $1.30M |
| Lonza Group AG | 0.80% | $1.29M |
| Quest Diagnostics Inc. | 0.74% | $1.20M |
| Alignment Healthcare, Inc. | 0.74% | $1.19M |
| Charles River Laboratories International, Inc. | 0.72% | $1.16M |
| Thermo Fisher Scientific Inc. | 0.71% | $1.14M |
| Ionis Pharmaceuticals, Inc. | 0.69% | $1.11M |
| IDEXX Laboratories, Inc. | 0.68% | $1.09M |
| Insmed Inc. | 0.65% | $1.04M |
| Twist Bioscience Corp. | 0.62% | $998.14K |
| Labcorp Holdings Inc. | 0.62% | $992.32K |
| Cytokinetics, Inc. | 0.59% | $951.74K |
| Steris PLC | 0.56% | $907.35K |
| Globus Medical, Inc. | 0.56% | $900.32K |
| Repligen Corp. | 0.52% | $838.83K |
| Rhythm Pharmaceuticals, Inc. | 0.51% | $822.51K |
| Tenet Healthcare Corp. | 0.48% | $773.39K |
| Krystal Biotech, Inc. | 0.46% | $731.45K |
| Praxis Precision Medicines, Inc. | 0.45% | $725.16K |
| Encompass Health Corp. | 0.44% | $704.53K |
| HCA Healthcare, Inc. | 0.43% | $692.83K |
| Mirum Pharmaceuticals, Inc. | 0.43% | $684.86K |
| Arrowhead Pharmaceuticals, Inc. | 0.39% | $630.64K |
| Regeneron Pharmaceuticals, Inc. | 0.39% | $624.79K |
| Medpace Holdings, Inc. | 0.37% | $598.44K |
| Rapport Therapeutics, Inc. | 0.37% | $596.21K |
| McKesson Corp. | 0.37% | $593.15K |
| BioLife Solutions, Inc. | 0.35% | $557.23K |
| LeMaitre Vascular, Inc. | 0.34% | $549.85K |
| BillionToOne, Inc. | 0.33% | $526.11K |
| RadNet, Inc. | 0.30% | $485.34K |
| Heartflow, Inc. | 0.29% | $462.57K |
| Dianthus Therapeutics, Inc. | 0.26% | $425.11K |
| Palvella Therapeutics, Inc. | 0.26% | $411.24K |
| Tarsus Pharmaceuticals, Inc. | 0.26% | $410.68K |
| Xenon Pharmaceuticals Inc. | 0.26% | $410.45K |
| Glaukos Corp. | 0.25% | $408.38K |
| Cogent Biosciences, Inc. | 0.23% | $373.92K |
| uniQure N.V. | 0.20% | $317.22K |
| Centene Corp. | 0.20% | $316.59K |
| Phathom Pharmaceuticals, Inc. | 0.16% | $261.04K |
| GMR Solutions Inc. | 0.15% | $241.93K |
| Mineralys Therapeutics, Inc. | 0.12% | $197.09K |
C000000433 overview: performance, fees, allocation and SEC filings